Dalid, Baby Girl .
HRN: 24-32-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
AMPICILLIN 250MG (VIAL)
03/14/2024
03/21/2024
IV
170 Mg
Q12H
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes